Evidence map›Paper›PMID 37291109›Full record

ArticleHuman vaccines & immunotherapeutics2023

Do vaccinations influence the development of Alzheimer disease?

Avram S Bukhbinder, Yaobin Ling, Kristofer Harris, Xiaoqian Jiang, Paul E Schulz

Open access · goldAbstract read
In one paragraph

Article in Human vaccines & immunotherapeutics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 26 citations in OpenAlex.

  1. Review
  2. Review
  3. Reduced risk of dementia with recombinant zoster vaccine in US adults age 65 or older.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  4. Article
  5. Article
  6. Is Alzheimer's an Autoimmune Disease?Molecular neurobiology · 2026
    Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Redox modulation of the complement cascade contributes to synapse loss in Alzheimer's disease.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2025
    Review
  13. Influenza vaccination in older people: a geriatrician's perspective.Aging clinical and experimental research · 2025
    Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Alzheimer's Disease: A Molecular Model and Implied Path to Improved Therapy.International journal of molecular sciences · 2024
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Avram S BukhbinderDepartment of Neurology, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX, USA.ORCID 0000-0002-7190-7676
Yaobin LingMcWilliams School of Biomedical Informatics, The University of Texas Health Science Center at Houston, Houston, TX, USA.ORCID 0000-0002-3183-1670
Kristofer HarrisDepartment of Neurology, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX, USA.ORCID 0000-0003-1250-6650
Xiaoqian JiangMcWilliams School of Biomedical Informatics, The University of Texas Health Science Center at Houston, Houston, TX, USA.ORCID 0000-0001-9933-2205
Paul E SchulzDepartment of Neurology, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX, USA.ORCID 0000-0003-0676-002X
The University of Texas Health Science Center at Houston · USMassachusetts General Hospital · US

Funding

Open Health Natural Language Processing CollaboratoryU01TR002062 · NCATS · MAYO CLINIC ROCHESTER · PI JIANG, XIAOQIAN, LIU, HONGFANG · 2017 to 2021
$7.6M
SHARE: Statistical Health Information Release with Differential PrivacyR01GM114612 · NIGMS · EMORY UNIVERSITY · PI XIONG, LI · 2015 to 2017
$1.0M
NCATS NIH HHS U01 TR002062NIGMS NIH HHS R01 GM114612
6 · The paper itself

Abstract

A growing literature supports a protective association between vaccines targeting an array of pathogens (e.g., influenza, pneumococcus, herpes zoster) and the risk of Alzheimer disease (AD). This article discusses the potential underlying mechanisms for this apparent protective effect of immunizations against infectious pathogens on the risk of AD; explores the basic and pharmacoepidemiologic evidence for this association, with particular attention paid to important methodological variations among the epidemiologic studies; and reviews the remaining uncertainties regarding the effects of anti-pathogen vaccines on Alzheimer disease and all-cause dementia, with recommendations for future directions to address those uncertainties.

Indexed as

Alzheimer DiseaseDiphtheria-Tetanus-acellular Pertussis VaccinesInfluenza, HumanInfluenza VaccinesHumansImmunizationVaccinationDiphtheria-Tetanus-acellular Pertussis VaccinesInfluenza VaccinesAlzheimer diseasedementiadiphtheria-tetanus-acellular pertussis vaccinesinfluenza vaccinesinnate immunityneuroimmunomodulationpharmacoepidemiologypneumococcal vaccinestrained immunityVaccines

Identifiers

PMID37291109
PMCPMC10332212
OpenAlexW4379967438

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.